Suraxavir trial finds faster flu recovery times for male but not female users
A single 40-mg dose of the antiviral drug suraxavir marboxil significantly shortened flu symptom resolution time in male patients aged 5–65, according to research led by the China-Japan Friendship Hospital in China. Intriguingly, ...